This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Company. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Albert Pak-Hung Li: Innovator in Bioartificial Liver Technology.
Introduction
Albert Pak-Hung Li is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of artificial organs. His innovative work focuses on creating solutions that can improve human health and medical treatments.
Latest Patents
Li holds a patent for a biological artificial liver. This invention involves a hepatocyte bioreactor or bioartificial liver that includes a containment vessel with a perfusion inlet and outlet. The matrix within the vessel is designed to entrap hepatocyte aggregates while allowing for the perfusion of the matrix. This invention is particularly useful as an artificial liver, providing a potential solution for patients with liver failure.
Career Highlights
Albert Pak-Hung Li is associated with Monsanto Company, where he has been able to apply his expertise in biotechnology. His work at Monsanto has allowed him to collaborate with other professionals in the field and contribute to advancements in agricultural and health-related technologies.
Collaborations
Li has worked alongside notable colleagues such as Timothy D. Whitehead and George E. Barker. Their combined efforts have fostered innovation and development in their respective areas of expertise.
Conclusion
Albert Pak-Hung Li's contributions to the field of bioartificial organs, particularly his patent for a biological artificial liver, highlight his role as an innovator in biotechnology. His work continues to pave the way for advancements in medical technology and patient care.